Oramed Pharma

$9.91 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Oramed Pharma

Oramed Pharmaceuticals, Inc. is a pharmaceutical company focused on the development of oral delivery solution. The Company is developing orally ingestible insulin capsules for the treatment diabetes as well as delivery solutions for other drugs and vaccines.

Stock Analysis

last close $9.48
1-mo return 12.3%
3-mo return 129%
avg daily vol. 788.34T
52-week high 31.54
52-week low 3.59
market cap. $368M
forward pe -
annual div. -
roe -36%
ltg forecast -
dividend yield -
annual rev. $9M
inst own. 21.1%

Subscribe now for daily local and international financial news